"RADIX" has signed an investment agreement

An investment agreement was signed between the Pharmaceutical Industry Development Agency and the drug manufacturer "RADIX".

According to the agreement, it is planned to launch a new enterprise on the territory of the innovation scientific and production pharmaceutics cluster Tashkent Pharma Park innovation scientific and production pharmaceutics cluster in order to expand the activities of the RADIX company and create 400 workplaces for the production of drugs in various forms (injection, infusion solutions, sterile antibiotics, tablets, capsules, candles as well as human insulin).

About "RADIX" : The company started its activity in 2002. Today, the enterprise employs more than 650 workers, and has 7 main production units: tablet, galen, ointment, infusion, injection, as well as dry shops for antibiotic dispensing and empty ampoule production.